Clovis Oncology Inc reports results for the quarter ended in December - Earnings Summary

Clovis Oncology

23/02/2022 14:33

* Clovis Oncology Inc  CLVS.OQ  reported a quarterly
adjusted loss
of 50 cents​​ per share for the quarter ended in December. The
mean expectation of four analysts for the quarter was for a loss
of 57 cents per share.
    * Revenue fell 16.9% to $35.97 million from a year ago; 
analysts
expected $37.65 million. 
    * Clovis Oncology Inc's reported EPS for the quarter was a
loss
of 50 cents​.
    * The mean earnings estimate of analysts had fallen by
about 6.7%
in the last three months.​ 
    * In the last 30 days two analysts negatively revised
earnings
estimates 
    * Clovis Oncology Inc shares had fallen by 37.6% this
quarter.
    * The company reported a quarterly loss of $64.39 million.
    * Wall Street's median 12-month price target for Clovis
Oncology
Inc is $3.00 
    * The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 1
"hold" and 2 "sell" or "strong sell." 

This summary was machine generated February 23 at 02:33 p.m.
 ​All figures in US dollars unless otherwise stated